HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (“Taro,” the “Company,” Pink Sheets: TAROF) announced that it has begun Phase I clinical trials in Canada with T2007, the second ...
HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (“Taro,” the “Company,” Pink Sheets: TAROF) announced that the U.S. Patent and Trademark Office has issued United States Patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results